Industry Research Reports

Home > Reports > Medical Devices & Consumables > Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-19

Pages: 129 Pages

Report ld: 3428542

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Diabetes Testing Program Market Size(US$)

CAGR 2025-2031

7.5%

Market Size,2031

USD 4,134

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 2,674 million

Market Forecast in 2031(Value)

US$ 4,134 million

CAGR

7.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Diabetes Testing Program was estimated to be worth US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.

A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.

The Global key players of Diabetes Testing Program include Roche, LifeScan, Abbott Laboratories, etc. The top three players hold a share over 44%. China is the largest market, and has a share about 33%. In terms of product type, HbA1c Test is the largest segment, which occupied for a share of about 66%. For application, Home Test is the largest segment, which has a share about 42%.

This report aims to provide a comprehensive presentation of the global market for Diabetes Testing Program, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Diabetes Testing Program by region & country, by Type, and by Application.

The Diabetes Testing Program market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Testing Program.

MARKET SEGMENTATION

By Company

Roche
LifeScan
Abbott Laboratories
Ascensia
Arkray
I-SENS
Omron
Braun
Siemens
Bio-Rad Laboratories
Tosoh
Danaher Corporation
Trinity Biotech
HUMAN Diagnostics
Terumo
Sinocare
Acon Biotech

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

HbA1c Test
Finger-prick Test

Segment by Application

Medical Diagnosis
Home Test
Lab Testing

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Diabetes Testing Program company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Diabetes Testing Program in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Diabetes Testing Program in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Diabetes Testing Program Product Introduction

1.2 Global Diabetes Testing Program Market Size Forecast (2020-2031)

1.3 Diabetes Testing Program Market Trends & Drivers

1.3.1 Diabetes Testing Program Industry Trends

1.3.2 Diabetes Testing Program Market Drivers & Opportunity

1.3.3 Diabetes Testing Program Market Challenges

1.3.4 Diabetes Testing Program Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Diabetes Testing Program Players Revenue Ranking (2024)

2.2 Global Diabetes Testing Program Revenue by Company (2020-2025)

2.3 Key Companies Diabetes Testing Program Manufacturing Base Distribution and Headquarters

2.4 Key Companies Diabetes Testing Program Product Offered

2.5 Key Companies Time to Begin Mass Production of Diabetes Testing Program

2.6 Diabetes Testing Program Market Competitive Analysis

2.6.1 Diabetes Testing Program Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Diabetes Testing Program Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Testing Program as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 HbA1c Test

3.1.2 Finger-prick Test

3.2 Global Diabetes Testing Program Sales Value by Type

3.2.1 Global Diabetes Testing Program Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Diabetes Testing Program Sales Value, by Type (2020-2031)

3.2.3 Global Diabetes Testing Program Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Medical Diagnosis

4.1.2 Home Test

4.1.3 Lab Testing

4.2 Global Diabetes Testing Program Sales Value by Application

4.2.1 Global Diabetes Testing Program Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Diabetes Testing Program Sales Value, by Application (2020-2031)

4.2.3 Global Diabetes Testing Program Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Diabetes Testing Program Sales Value by Region

5.1.1 Global Diabetes Testing Program Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Diabetes Testing Program Sales Value by Region (2020-2025)

5.1.3 Global Diabetes Testing Program Sales Value by Region (2026-2031)

5.1.4 Global Diabetes Testing Program Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Diabetes Testing Program Sales Value, 2020-2031

5.2.2 North America Diabetes Testing Program Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Diabetes Testing Program Sales Value, 2020-2031

5.3.2 Europe Diabetes Testing Program Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Diabetes Testing Program Sales Value, 2020-2031

5.4.2 Asia Pacific Diabetes Testing Program Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Diabetes Testing Program Sales Value, 2020-2031

5.5.2 South America Diabetes Testing Program Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Diabetes Testing Program Sales Value, 2020-2031

5.6.2 Middle East & Africa Diabetes Testing Program Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Diabetes Testing Program Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Diabetes Testing Program Sales Value, 2020-2031

6.3 United States

6.3.1 United States Diabetes Testing Program Sales Value, 2020-2031

6.3.2 United States Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Diabetes Testing Program Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Diabetes Testing Program Sales Value, 2020-2031

6.4.2 Europe Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Diabetes Testing Program Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Diabetes Testing Program Sales Value, 2020-2031

6.5.2 China Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

6.5.3 China Diabetes Testing Program Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Diabetes Testing Program Sales Value, 2020-2031

6.6.2 Japan Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Diabetes Testing Program Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Diabetes Testing Program Sales Value, 2020-2031

6.7.2 South Korea Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Diabetes Testing Program Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Diabetes Testing Program Sales Value, 2020-2031

6.8.2 Southeast Asia Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Diabetes Testing Program Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Diabetes Testing Program Sales Value, 2020-2031

6.9.2 India Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

6.9.3 India Diabetes Testing Program Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Roche

7.1.1 Roche Profile

7.1.2 Roche Main Business

7.1.3 Roche Diabetes Testing Program Products, Services and Solutions

7.1.4 Roche Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.1.5 Roche Recent Developments

7.2 LifeScan

7.2.1 LifeScan Profile

7.2.2 LifeScan Main Business

7.2.3 LifeScan Diabetes Testing Program Products, Services and Solutions

7.2.4 LifeScan Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.2.5 LifeScan Recent Developments

7.3 Abbott Laboratories

7.3.1 Abbott Laboratories Profile

7.3.2 Abbott Laboratories Main Business

7.3.3 Abbott Laboratories Diabetes Testing Program Products, Services and Solutions

7.3.4 Abbott Laboratories Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.3.5 Abbott Laboratories Recent Developments

7.4 Ascensia

7.4.1 Ascensia Profile

7.4.2 Ascensia Main Business

7.4.3 Ascensia Diabetes Testing Program Products, Services and Solutions

7.4.4 Ascensia Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.4.5 Ascensia Recent Developments

7.5 Arkray

7.5.1 Arkray Profile

7.5.2 Arkray Main Business

7.5.3 Arkray Diabetes Testing Program Products, Services and Solutions

7.5.4 Arkray Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.5.5 Arkray Recent Developments

7.6 I-SENS

7.6.1 I-SENS Profile

7.6.2 I-SENS Main Business

7.6.3 I-SENS Diabetes Testing Program Products, Services and Solutions

7.6.4 I-SENS Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.6.5 I-SENS Recent Developments

7.7 Omron

7.7.1 Omron Profile

7.7.2 Omron Main Business

7.7.3 Omron Diabetes Testing Program Products, Services and Solutions

7.7.4 Omron Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.7.5 Omron Recent Developments

7.8 Braun

7.8.1 Braun Profile

7.8.2 Braun Main Business

7.8.3 Braun Diabetes Testing Program Products, Services and Solutions

7.8.4 Braun Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.8.5 Braun Recent Developments

7.9 Siemens

7.9.1 Siemens Profile

7.9.2 Siemens Main Business

7.9.3 Siemens Diabetes Testing Program Products, Services and Solutions

7.9.4 Siemens Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.9.5 Siemens Recent Developments

7.10 Bio-Rad Laboratories

7.10.1 Bio-Rad Laboratories Profile

7.10.2 Bio-Rad Laboratories Main Business

7.10.3 Bio-Rad Laboratories Diabetes Testing Program Products, Services and Solutions

7.10.4 Bio-Rad Laboratories Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.10.5 Bio-Rad Laboratories Recent Developments

7.11 Tosoh

7.11.1 Tosoh Profile

7.11.2 Tosoh Main Business

7.11.3 Tosoh Diabetes Testing Program Products, Services and Solutions

7.11.4 Tosoh Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.11.5 Tosoh Recent Developments

7.12 Danaher Corporation

7.12.1 Danaher Corporation Profile

7.12.2 Danaher Corporation Main Business

7.12.3 Danaher Corporation Diabetes Testing Program Products, Services and Solutions

7.12.4 Danaher Corporation Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.12.5 Danaher Corporation Recent Developments

7.13 Trinity Biotech

7.13.1 Trinity Biotech Profile

7.13.2 Trinity Biotech Main Business

7.13.3 Trinity Biotech Diabetes Testing Program Products, Services and Solutions

7.13.4 Trinity Biotech Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.13.5 Trinity Biotech Recent Developments

7.14 HUMAN Diagnostics

7.14.1 HUMAN Diagnostics Profile

7.14.2 HUMAN Diagnostics Main Business

7.14.3 HUMAN Diagnostics Diabetes Testing Program Products, Services and Solutions

7.14.4 HUMAN Diagnostics Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.14.5 HUMAN Diagnostics Recent Developments

7.15 Terumo

7.15.1 Terumo Profile

7.15.2 Terumo Main Business

7.15.3 Terumo Diabetes Testing Program Products, Services and Solutions

7.15.4 Terumo Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.15.5 Terumo Recent Developments

7.16 Sinocare

7.16.1 Sinocare Profile

7.16.2 Sinocare Main Business

7.16.3 Sinocare Diabetes Testing Program Products, Services and Solutions

7.16.4 Sinocare Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.16.5 Sinocare Recent Developments

7.17 Acon Biotech

7.17.1 Acon Biotech Profile

7.17.2 Acon Biotech Main Business

7.17.3 Acon Biotech Diabetes Testing Program Products, Services and Solutions

7.17.4 Acon Biotech Diabetes Testing Program Revenue (US$ Million) & (2020-2025)

7.17.5 Acon Biotech Recent Developments

8 Industry Chain Analysis

8.1 Diabetes Testing Program Industrial Chain

8.2 Diabetes Testing Program Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Diabetes Testing Program Sales Model

8.5.2 Sales Channel

8.5.3 Diabetes Testing Program Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Diabetes Testing Program Market Trends

Table 2. Diabetes Testing Program Market Drivers & Opportunity

Table 3. Diabetes Testing Program Market Challenges

Table 4. Diabetes Testing Program Market Restraints

Table 5. Global Diabetes Testing Program Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Diabetes Testing Program Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Diabetes Testing Program Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Diabetes Testing Program Product Type

Table 9. Key Companies Time to Begin Mass Production of Diabetes Testing Program

Table 10. Global Diabetes Testing Program Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Testing Program as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Diabetes Testing Program Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Diabetes Testing Program Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Diabetes Testing Program Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Diabetes Testing Program Sales Market Share in Value by Type (2020-2025)

Table 17. Global Diabetes Testing Program Sales Market Share in Value by Type (2026-2031)

Table 18. Global Diabetes Testing Program Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Diabetes Testing Program Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Diabetes Testing Program Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Diabetes Testing Program Sales Market Share in Value by Application (2020-2025)

Table 22. Global Diabetes Testing Program Sales Market Share in Value by Application (2026-2031)

Table 23. Global Diabetes Testing Program Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Diabetes Testing Program Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Diabetes Testing Program Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Diabetes Testing Program Sales Value by Region (2020-2025) & (%)

Table 27. Global Diabetes Testing Program Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Diabetes Testing Program Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Diabetes Testing Program Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Diabetes Testing Program Sales Value, (2026-2031) & (US$ Million)

Table 31. Roche Basic Information List

Table 32. Roche Description and Business Overview

Table 33. Roche Diabetes Testing Program Products, Services and Solutions

Table 34. Revenue (US$ Million) in Diabetes Testing Program Business of Roche (2020-2025)

Table 35. Roche Recent Developments

Table 36. LifeScan Basic Information List

Table 37. LifeScan Description and Business Overview

Table 38. LifeScan Diabetes Testing Program Products, Services and Solutions

Table 39. Revenue (US$ Million) in Diabetes Testing Program Business of LifeScan (2020-2025)

Table 40. LifeScan Recent Developments

Table 41. Abbott Laboratories Basic Information List

Table 42. Abbott Laboratories Description and Business Overview

Table 43. Abbott Laboratories Diabetes Testing Program Products, Services and Solutions

Table 44. Revenue (US$ Million) in Diabetes Testing Program Business of Abbott Laboratories (2020-2025)

Table 45. Abbott Laboratories Recent Developments

Table 46. Ascensia Basic Information List

Table 47. Ascensia Description and Business Overview

Table 48. Ascensia Diabetes Testing Program Products, Services and Solutions

Table 49. Revenue (US$ Million) in Diabetes Testing Program Business of Ascensia (2020-2025)

Table 50. Ascensia Recent Developments

Table 51. Arkray Basic Information List

Table 52. Arkray Description and Business Overview

Table 53. Arkray Diabetes Testing Program Products, Services and Solutions

Table 54. Revenue (US$ Million) in Diabetes Testing Program Business of Arkray (2020-2025)

Table 55. Arkray Recent Developments

Table 56. I-SENS Basic Information List

Table 57. I-SENS Description and Business Overview

Table 58. I-SENS Diabetes Testing Program Products, Services and Solutions

Table 59. Revenue (US$ Million) in Diabetes Testing Program Business of I-SENS (2020-2025)

Table 60. I-SENS Recent Developments

Table 61. Omron Basic Information List

Table 62. Omron Description and Business Overview

Table 63. Omron Diabetes Testing Program Products, Services and Solutions

Table 64. Revenue (US$ Million) in Diabetes Testing Program Business of Omron (2020-2025)

Table 65. Omron Recent Developments

Table 66. Braun Basic Information List

Table 67. Braun Description and Business Overview

Table 68. Braun Diabetes Testing Program Products, Services and Solutions

Table 69. Revenue (US$ Million) in Diabetes Testing Program Business of Braun (2020-2025)

Table 70. Braun Recent Developments

Table 71. Siemens Basic Information List

Table 72. Siemens Description and Business Overview

Table 73. Siemens Diabetes Testing Program Products, Services and Solutions

Table 74. Revenue (US$ Million) in Diabetes Testing Program Business of Siemens (2020-2025)

Table 75. Siemens Recent Developments

Table 76. Bio-Rad Laboratories Basic Information List

Table 77. Bio-Rad Laboratories Description and Business Overview

Table 78. Bio-Rad Laboratories Diabetes Testing Program Products, Services and Solutions

Table 79. Revenue (US$ Million) in Diabetes Testing Program Business of Bio-Rad Laboratories (2020-2025)

Table 80. Bio-Rad Laboratories Recent Developments

Table 81. Tosoh Basic Information List

Table 82. Tosoh Description and Business Overview

Table 83. Tosoh Diabetes Testing Program Products, Services and Solutions

Table 84. Revenue (US$ Million) in Diabetes Testing Program Business of Tosoh (2020-2025)

Table 85. Tosoh Recent Developments

Table 86. Danaher Corporation Basic Information List

Table 87. Danaher Corporation Description and Business Overview

Table 88. Danaher Corporation Diabetes Testing Program Products, Services and Solutions

Table 89. Revenue (US$ Million) in Diabetes Testing Program Business of Danaher Corporation (2020-2025)

Table 90. Danaher Corporation Recent Developments

Table 91. Trinity Biotech Basic Information List

Table 92. Trinity Biotech Description and Business Overview

Table 93. Trinity Biotech Diabetes Testing Program Products, Services and Solutions

Table 94. Revenue (US$ Million) in Diabetes Testing Program Business of Trinity Biotech (2020-2025)

Table 95. Trinity Biotech Recent Developments

Table 96. HUMAN Diagnostics Basic Information List

Table 97. HUMAN Diagnostics Description and Business Overview

Table 98. HUMAN Diagnostics Diabetes Testing Program Products, Services and Solutions

Table 99. Revenue (US$ Million) in Diabetes Testing Program Business of HUMAN Diagnostics (2020-2025)

Table 100. HUMAN Diagnostics Recent Developments

Table 101. Terumo Basic Information List

Table 102. Terumo Description and Business Overview

Table 103. Terumo Diabetes Testing Program Products, Services and Solutions

Table 104. Revenue (US$ Million) in Diabetes Testing Program Business of Terumo (2020-2025)

Table 105. Terumo Recent Developments

Table 106. Sinocare Basic Information List

Table 107. Sinocare Description and Business Overview

Table 108. Sinocare Diabetes Testing Program Products, Services and Solutions

Table 109. Revenue (US$ Million) in Diabetes Testing Program Business of Sinocare (2020-2025)

Table 110. Sinocare Recent Developments

Table 111. Acon Biotech Basic Information List

Table 112. Acon Biotech Description and Business Overview

Table 113. Acon Biotech Diabetes Testing Program Products, Services and Solutions

Table 114. Revenue (US$ Million) in Diabetes Testing Program Business of Acon Biotech (2020-2025)

Table 115. Acon Biotech Recent Developments

Table 116. Key Raw Materials Lists

Table 117. Raw Materials Key Suppliers Lists

Table 118. Diabetes Testing Program Downstream Customers

Table 119. Diabetes Testing Program Distributors List

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Diabetes Testing Program Product Picture

Figure 2. Global Diabetes Testing Program Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Diabetes Testing Program Sales Value (2020-2031) & (US$ Million)

Figure 4. Diabetes Testing Program Report Years Considered

Figure 5. Global Diabetes Testing Program Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Diabetes Testing Program Revenue in 2024

Figure 7. Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. HbA1c Test Picture

Figure 9. Finger-prick Test Picture

Figure 10. Global Diabetes Testing Program Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Diabetes Testing Program Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Medical Diagnosis

Figure 13. Product Picture of Home Test

Figure 14. Product Picture of Lab Testing

Figure 15. Global Diabetes Testing Program Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Diabetes Testing Program Sales Value Market Share by Application, 2024 & 2031

Figure 17. North America Diabetes Testing Program Sales Value (2020-2031) & (US$ Million)

Figure 18. North America Diabetes Testing Program Sales Value by Country (%), 2024 VS 2031

Figure 19. Europe Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 20. Europe Diabetes Testing Program Sales Value by Country (%), 2024 VS 2031

Figure 21. Asia Pacific Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 22. Asia Pacific Diabetes Testing Program Sales Value by Region (%), 2024 VS 2031

Figure 23. South America Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 24. South America Diabetes Testing Program Sales Value by Country (%), 2024 VS 2031

Figure 25. Middle East & Africa Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 26. Middle East & Africa Diabetes Testing Program Sales Value by Country (%), 2024 VS 2031

Figure 27. Key Countries/Regions Diabetes Testing Program Sales Value (%), (2020-2031)

Figure 28. United States Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 29. United States Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

Figure 30. United States Diabetes Testing Program Sales Value by Application (%), 2024 VS 2031

Figure 31. Europe Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

Figure 33. Europe Diabetes Testing Program Sales Value by Application (%), 2024 VS 2031

Figure 34. China Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 35. China Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

Figure 36. China Diabetes Testing Program Sales Value by Application (%), 2024 VS 2031

Figure 37. Japan Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 38. Japan Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

Figure 39. Japan Diabetes Testing Program Sales Value by Application (%), 2024 VS 2031

Figure 40. South Korea Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 41. South Korea Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

Figure 42. South Korea Diabetes Testing Program Sales Value by Application (%), 2024 VS 2031

Figure 43. Southeast Asia Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

Figure 45. Southeast Asia Diabetes Testing Program Sales Value by Application (%), 2024 VS 2031

Figure 46. India Diabetes Testing Program Sales Value, (2020-2031) & (US$ Million)

Figure 47. India Diabetes Testing Program Sales Value by Type (%), 2024 VS 2031

Figure 48. India Diabetes Testing Program Sales Value by Application (%), 2024 VS 2031

Figure 49. Diabetes Testing Program Industrial Chain

Figure 50. Diabetes Testing Program Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 7.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

Which companies rank high in the global Diabetes Testing Program market? shouQi

What was the global market size of Diabetes Testing Program in 2025? shouQi

What was the global market size of Diabetes Testing Program in 2031? shouQi

What is the annual compound growth rate of the global Diabetes Testing Program market size from 2025 to 2031? shouQi

Related Reports

Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 105
USD 4250.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2026
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 126
USD 2900.00
(Single User License)
Diabetes Testing Program - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 137
USD 3950.00
(Single User License)
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 104
USD 4250.00
(Single User License)
Global Diabetes Testing Program Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 152
USD 4900.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2025
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-01-19
Pages: 92
USD 2900.00
(Single User License)
Global and United States Diabetes Testing Program Market Report & Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 122
USD 4350.00
(Single User License)
Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 125
USD 3950.00
(Single User License)
Global Diabetes Testing Program Market Research Report 2024
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published Date: 2024-04-19
Pages: 99
USD 2900.00
(Single User License)
Global Diabetes Testing Program Market Insights, Forecast to 2030
Published Date: 2024-03-20
Pages: 197
USD 4900.00
(Single User License)

Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Diabetes Testing Program market size was US$ 2674 million in 2025 and is forecast to reach a readjusted size of US$ 4414 million by 2032 with a CAGR of 7.5% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 105
USD 4250.00 (Single User License)
Global Diabetes Testing Program Market Research Report 2026
The global Diabetes Testing Program market was valued at US$ 2674 million in 2025 and is anticipated to reach US$ 4414 million by 2032, at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 126
USD 2900.00 (Single User License)
Diabetes Testing Program - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Diabetes Testing Program was estimated to be worth US$ 2674 million in 2025 and is projected to reach US$ 4414 million, growing at a CAGR of 7.5% from 2026 to 2032.
Published: 2026-01-05
Pages: 137
USD 3950.00 (Single User License)
Global Diabetes Testing Program Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Diabetes Testing Program market size was US$ 2504 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 104
USD 4250.00 (Single User License)
Global Diabetes Testing Program Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Diabetes Testing Program market is projected to grow from US$ 2504 million in 2024 to US$ 4134 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 152
USD 4900.00 (Single User License)
Global Diabetes Testing Program Market Research Report 2025
The global market for Diabetes Testing Program was valued at US$ 2504 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-01-19
Pages: 92
USD 2900.00 (Single User License)
Global and United States Diabetes Testing Program Market Report & Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 122
USD 4350.00 (Single User License)
Diabetes Testing Program- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 125
USD 3950.00 (Single User License)
Global Diabetes Testing Program Market Research Report 2024
A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
Published: 2024-04-19
Pages: 99
USD 2900.00 (Single User License)
Global Diabetes Testing Program Market Insights, Forecast to 2030
Published: 2024-03-20
Pages: 197
USD 4900.00 (Single User License)